TwoLegs Consulting

Change the Paradigm // Start with the Patient

Menu

Skip to content
  • Home
  • About
  • Why TwoLegs?
  • Services
    • Patient-Centered Drug Development
    • Patient-Centered Market Access
    • Clinical Outcome Assessments
    • Regulatory Endorsement / Qualification
    • Thought Leadership and Coaching
    • Externalization of Senior Leadership
  • Experience
    • Founder
    • Recent Work
    • Publications
  • News
  • Contact

Clinical outcome assessment qualification program

Patrick Marquis / November 10, 2013

The FDA has released a road map to patient-focused outcome measurement in clinical trials.

http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm284077.htm

For questions and implementation please contact patrick.marquis@twolegs-consulting.com

November 10, 2013 in Regulatory News. Tags: Biotechnology and Pharmaceuticals, FDA

Related posts

FDA News

Post navigation

← FDA News
Blog at WordPress.com.